MedPath

Oncorena AB

Oncorena AB logo
🇳🇴Norway
Ownership
Subsidiary
Established
2011-01-01
Employees
11
Market Cap
-
Website
http://www.oncorena.com

Clinical Trials

3

Active:2
Completed:0

Trial Phases

1 Phases

Phase 1:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 1
3 (100.0%)

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

Phase 1
Recruiting
Conditions
Carcinoma, Renal Cell
Interventions
First Posted Date
2022-03-18
Last Posted Date
2024-06-24
Lead Sponsor
Oncorena AB
Target Recruit Count
50
Registration Number
NCT05287945
Locations
🇸🇪

Karolinska University Hospital, Stockholm, Sweden

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.